RPg Family Wealth Advisory’s Novo Nordisk NVO Stock Holding History

RPg Family Wealth Advisory’s Portfolio NVO Stock Details NVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-438	Closed	-$10.3K	–	246
2018 Q3	$10.3K	Buy	+438	New	+$10.7K	0.01%	251
2017 Q1	–	Sell	-726	Closed	-$13K	–	317
2016 Q4	$13K	Buy	+726	New	+$13.2K	0.01%	234
2016 Q1	–	Sell	-183,196	Closed	-$5.32M	–	282
2015 Q4	$5.32M	Buy	+183,196	New	+$5.07M	4.89%	3

Other funds holding NVO

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Fayez Sarofim & Co Houston, Texas $39.1B AUM 15.14% 1-Year Est. Return

RPg Family Wealth Advisory's NVO Position: Q4 2018 in Review

RPg Family Wealth Advisory sold out of Novo Nordisk (NVO) in Q4 2018, closing a stake of 438 shares — an estimated $10.3K sold.

RPg Family Wealth Advisory first reported a position in NVO in Q4 2015 and held it in 3 quarters. The position peaked at $5.32M in Q4 2015. 550 funds tracked by Wall St. Rank hold NVO as of Q4 2018.

RPg Family Wealth Advisory reported no remaining Novo Nordisk position as of Q4 2018 after selling out during the quarter.
RPg Family Wealth Advisory sold 438 Novo Nordisk shares in Q4 2018, an estimated $10.3K.
RPg Family Wealth Advisory first reported a position in Novo Nordisk in Q4 2015 and held it in 3 quarters.
RPg Family Wealth Advisory's Novo Nordisk position peaked at $5.32M in Q4 2015.
550 funds tracked by Wall St. Rank held Novo Nordisk as of Q4 2018.

Based on RPg Family Wealth Advisory's 13F filing for Q4 2018, filed 14 Feb 2019.